ENTRY       D09746                      Drug
NAME        Dalotuzumab (USAN)
SEQUENCE    (A chain)
            QVQLQESGPG LVKPSETLSL TCTVSGYSIT GGYLWNWIRQ PPGKGLEWIG YISYDGTNNY
            KPSLKDRVTI SRDTSKNQFS LKLSSVTAAD TAVYYCARYG RVFFDYWGQG TLVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKRVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (B chain)
            DIVMTQSPLS LPVTPGEPAS ISCRSSQSIV HSNGNTYLQW YLQKPGQSPQ LLIYKVSNRL
            YGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCFQGSHVP WTFGQGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: A22-A96, A144-A200, A261-A321, A367-A425, A226-A'226, A229-A'229, B23-B93, B139-B199, A220-B219, A'220-B'219)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-insulin-like growth factor (IGF) 1 receptor antibody
  TYPE      Monoclonal antibody
TARGET      IGF1R (CD221) [HSA:3480] [KO:K05087]
  PATHWAY   hsa04510(3480)  Focal adhesion
            hsa04520(3480)  Adherens junction
            hsa05200(3480)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                IGF1R (CD221)
                 D09746  Dalotuzumab (USAN)
DBLINKS     CAS: 1005389-60-5
            PubChem: 124490486
///
